Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

6.80
+0.38005.92%
Volume:291.81K
Turnover:1.93M
Market Cap:263.98M
PE:-1.71
High:6.81
Open:6.49
Low:6.29
Close:6.42
52wk High:16.45
52wk Low:5.02
Shares:38.82M
Float Shares:22.98M
Volume Ratio:0.70
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9676
EPS(LYR):-3.4746
ROE:-54.09%
ROA:-29.20%
PB:1.13
PE(LYR):-1.96

Loading ...

Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 04, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report